Ori Biotech: Funding, Investors & Team (Sep 2026)
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
Ori Biotech has raised $130M across 2 funding rounds on record, the most recent a Series B of $100M announced in Jan 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ori Biotech Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Ori Biotech Funding Rounds
Ori Biotech raised $30.0M in an undisclosed round announced in Oct 2020.
1.3 years later, a Series B of $100M was announced in Jan 2022.
Ori Biotech Founders and Leadership Team
Contact details for the Ori Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Ori Biotech Funding Compared to Other Biotechnology Startups
Ori Biotech's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ori Biotech in Biotechnology and London
Companies Similar to Ori Biotech
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Ori Biotech Funding FAQs
What does Ori Biotech do?
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
How much funding has Ori Biotech raised?
Ori Biotech has raised $130M across 2 rounds on record. The most recent is a Series B of $100M announced in Jan 2022.
When did Ori Biotech last raise funding?
Ori Biotech's most recent funding round on record is a Series B of $100M, announced in Jan 2022.
Who is the CEO of Ori Biotech?
Jason Foster is listed as CEO at Ori Biotech.
Where is Ori Biotech headquartered?
Ori Biotech is based in London, England, United Kingdom.
How many employees does Ori Biotech have?
Ori Biotech is in the 11-50 employee band.
How does Ori Biotech's funding compare to other Biotechnology startups?
Ori Biotech's latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Ori Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ori Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.